UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549
                                  _____________

                                    Form 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reportedly): April 16, 2007


                              OCEAN BIO-CHEM, INC.
               (Exact name of registrant as specified in charter)

         Florida                            0-11102               59-1564329
     (State or Other               (Commission File Number)    (I.R.S. Employer
Jurisdiction of Incorporation)                               Identification No.)

               4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
                (Address of principal executive office Zip Code)

                                 (954) 587-6280
               Registrant's telephone number, including area code:

                                 Not Applicable
          (Former name or former address, if changes since last report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions:

     [ ] Written  communications  pursuant to Rule 425 under the  Securities Act
(17 CFR 230.425)

     [ ] Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

     [ ]  Pre-commencement  communications  pursuant to Rule 14d-2(b)  under the
Exchange Act (17 CFR 240.14d-2(b))

     [ ]  Pre-commencement  communications  pursuant to Rule 13e-4(c)  under the
Exchange Act (17 CFR 240.13e-4(c))




Item 1.01 - Entry into a Material Definitive Agreement


     On April 16, 2007 the Company's  Board of Directors  adopted the 2007 Ocean
Bio-Chem,  Inc.  Incentive  Stock  Option  Plan.  Such Plan  covers a maximum of
400,000 options for the Company's  underlying  common stock.  A copy of the Plan
is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.


 Item 9.01  Financial Statements and Exhibits

     (c ) Exhibits- 99.1 Ocean Bio-Chem, Inc. Incentive Stock OPtion Plan






                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

April 18, 2007
                                        Ocean Bio-Chem, Inc.

                                        /s/ Peter G. Dornau
                                        ----------------------------
                                        Peter G. Dornau
                                        Chairman of the Board and
                                        Chief Executive Officer








                                                                   Exhibit  99.1

                              OCEAN BIO-CHEM, INC.

                        2007 INCENTIVE STOCK OPTION PLAN

                            EFFECTIVE APRIL 16, 2007


                                   1. PURPOSE

     1.1 GENERAL.  Ocean Bio-Chem,  Inc., a Florida corporation (the "Company"),
established  this  Incentive  Stock  Option  Plan (the  "Plan") to  further  the
Company's  growth  and  development  by  providing  to  officers  and  other key
employees  who are in a position to contribute  materially to the  prosperity of
the Company, through ownership of stock of the Company, an incentive to increase
their  interest in the  Company's  welfare,  to continue  their  services and to
afford a means  through  which the  Company  can  attract to its  service  other
employees of outstanding ability.

     1.2 COMPANY. For purposes of the Plan, the Company is deemed to include all
wholly owned subsidiaries of the Company.

     1.3 TAX  TREATMENT.  The Plan is adopted  with the  intent  that it be, and
continue  to be, an  "incentive  stock  option  plan"  entitling  the holders of
options to the special  tax  treatment  provided by Section 422 of the  Internal
Revenue Code of 1986 (the "Code").

                                2. ADMINISTRATION

     2.1 STOCK OPTION  COMMITTEE.  The Plan shall be  administered  by the Ocean
Bio-Chem,  Inc.,  Stock Option Plan Committee (the  "Committee")  which shall be
composed of at least two Non-Employee  directors of the Company.  The Committee,
to be appointed by the Board of  Directors,  shall have full and complete  power
and authority to do all things  necessary and proper for the  administration  of
the Plan, including the power to interpret and construe its terms and provisions
and to  determine,  consistent  with the  terms  of the  Plan,  the  individuals
selected to receive options,  the times when they shall receive them, the number
of shares to be subject to each option, and the option price.

     2.2 RULES AND  REGULATIONS.  The Committee,  as it may deem advisable,  may
issue rules and regulations for the administration of the Plan. When so directed
by the Committee,  appropriate officers of the Company shall execute and deliver
on behalf of the Company such options,  agreements and other  instruments as the
Committee  may  determine  necessary  to the  implementation  of the  Plan.  The
Committee may adopt and/or construe an appropriate  form for any such options or
agreements  and  instruments,  which  forms shall  contain  such  provisions  or
conditions  as the  Committee  deems  necessary or advisable in carrying out the
purposes of the Plan,  provided,  however,  that no such  provision or condition
shall be inconsistent with the Plan.

     2.3 DEFECTS OR  OMISSIONS.  The  Committee may correct any defect or supply
any  omission or  reconcile  any  inconsistency  in the Plan or in any option or
agreement  in the manner and to the extent it shall deem  expedient  to carry it
into effect,  and to meet the requirements of Section 422 of the Code, and shall
be the sole and final judge of such  expediency.  The Committee's  determination
shall be conclusive.


                          3. STOCK SUBJECT TO THE PLAN

     3.1 NUMBER OF SHARES.  Shares of the Company's Common Stock, par value $.01
per share  ("Common  Stock")  shall be subject to the Plan.  The total number of
shares of Common Stock which may be sold  pursuant to options  granted under the
Plan  ("Option"  or  "Options")  shall not exceed  400,000  shares,  adjusted as
provided in Section  3.2.  The shares of Common Stock sold under the Plan may be
either  authorized  and  unissued  shares or  issued  shares  reacquired  by the
Company.  Unless and until the Board of  Directors  shall  determine to purchase
shares in the market for the purpose of the Plan or to use treasury shares,  the
shares sold under the Plan shall be authorized and unissued  shares reserved for
that  purpose.  In the event  that any  Options  granted  under  the Plan  shall
terminate or expire for any reason  without  having been  exercised in full, the
shares of Common  Stock not  purchased  under those  Options  shall be available
again for the purpose of the Plan.


     3.2  ADJUSTMENTS.  Notwithstanding  any other provision of the Plan, in the
event of any change in any shares of the outstanding Common Stock of the Company
by  reason  of  a  stock  dividend,  recapitalization,   merger,  consolidation,
split-up,  stock split, reverse stock split,  combination or exchange of shares,
or action of like nature,  the aggregate  number and class of shares as to which
Options may be granted to any individual, the number and class of shares subject
to each outstanding Option and the Option prices shall be appropriately adjusted
in  proportion  to  such  increases  or  decreases  by  the   Committee,   whose
determination shall be conclusive.

     3.2 REVERSION OF SHARES TO THE SHARE RESERVE.  If any Stock Award shall for
any reason expire or otherwise  terminate,  in whole or in part,  without having
been exercised in full, the shares of Common Stock not acquired under such Stock
Award shall revert to and again become available for issuance under the Plan.

     3.3 SOURCE OF SHARES. The shares of Common Stock subject to the Plan may be
unissued shares or reacquired shares, bought on the market or otherwise.

                        4. ELIGIBILITY AND PARTICIPATION

     4.1  INCENTIVE  STOCK OPTION  $100,000  LIMITATION.  To the extent that the
aggregate  Fair Market Value  (determined  at the time of grant) of Common Stock
with respect to which Incentive Stock Options are exercisable for the first time
by any Option  holder  during any calendar  year (under all plans of the Company
and its Affiliates) exceeds one hundred thousand dollars ($100,000), the Options
or portions  thereof  which exceed such limit  (according  to the order in which
they were granted) shall be treated as Non-statutory Stock Options.

     4.2  OFFICERS  AND  CERTAIN  EMPLOYEES.  Options  may be  granted  only  to
full-time  salaried  officers  and key  employees  of the  Company or any of its
subsidiaries.  Directors  of the  Company  who are not also  full-time  salaried
officers or employees of the Company will not be eligible to receive Options.

     4.2 TEN PERCENT SHAREHOLDER LIMITATION. If an Option is to be granted to an
individual who, at the time the Option is granted,  owns Common Stock possessing
more than 10 percent (10%) of the total combined  voting power of all classes of
stock of the Company or of its parent or subsidiary (as determined under Section
425(d) of the Code),  the  purchase  price of the Common Stock under each Option
("Option  Price") set out in the  applicable  portion of Article 5 hereof  shall
read "but shall be at least 110 percent of its Fair Market Value" and the period
of exercise  set out in the  applicable  portion of Article 6 hereof  shall read
"and  ending not more than five (5) years  after the date on which the option is
granted".

                                    5. PRICE

     5.1  DETERMINATION.  The Option Price shall be determined by the Committee,
but shall not be less than 100 percent of its fair market  value (as  determined
by Section 422 of the Code) ("Fair Market Value") at the time of granting of the
Option, as determined in good faith by the Committee.

     5.2 PAYMENT. Upon exercise of the Option, the Option Price shall be paid in
full with cash or with stock of the  Company  or with  demand  promissory  notes
bearing the rate of interest required by the Code, as amended from time to time,
at the option of the  Employee or Option  holder may, at his option,  in lieu of
paying the Option Price upon  exercise of the Option elect to instead  receive a
number of Option Shares computed using the following formula:

                                  X + Y(A - B)
                                        A

where:  X = the number of Option Shares  issuable to Option holder upon exercise
under this Section 5; Y = the number of Option Shares  issuable to Option holder
upon  exercise  under  Section 5 hereof;  A = the Fair Market  Value (as defined
below) of one share of Common Stock as of the exercise  date; and B = the Option
Price.

     (b) As used in this  Section  5, "Fair  Market  Value" of a share of Common
Stock on any  particular  date shall mean:  The closing  price for the Company's
Common Stock on the principal market for such Common Stock on the date preceding
the exercise date  (provided  such notice and  designation of exercise date must
take place  subsequent to the closing of the principal  markets and prior to the
opening of the principal market on the following day).


     5.3 USE OF PROCEEDS. The proceeds from the issuance of Common Stock subject
to Options are to be added to the funds of the Company available for its general
corporate purposes.

                              6. EXERCISE OF OPTION

     6.1  PERIOD OF  EXERCISE.  Each  Option  granted  under  the Plan  shall be
exercisable  only during such period as the Committee may  determine,  beginning
not less than one (1) year and  ending  not more than ten (10)  years  after the
date on which the Option is granted ("Expiration  Date"),  except as such period
may be modified under the provisions or Sections 8.1 and 9.1 hereof. Within such
limits each Option shall provide,  as determined by the  Committee,  the time or
times at which and the  number of shares for which it may be  exercised.  Unless
otherwise provided in the Committee's  action,  each Option shall be exercisable
in whole at any  time,  or in part  from  time to time,  during  the term of the
Option.  The  holder of an Option  shall  have no rights as a  shareholder  with
respect to shares subject to the Option until such shares shall have been issued
to him upon  exercise  of the  Option.  An Option  may be  exercised  during the
lifetime of the holder  thereof  only by such  holder,  and,  after the holder's
death, as provided in Sections 9.1 and 9.2 hereof.

     6.2  CHANGE  OF  CONTROL.  Provided  however,  in the  event of a change in
control  of  Company,  each  Option  granted  under  this  Plan  shall  be fully
exercisable.


     6.3 SALE. An individual  who has acquired  Common Stock upon exercise of an
Option may not sell,  transfer  or  otherwise  dispose  of the  Common  Stock so
acquired within two years from the date of the granting of the Option nor within
one year after the transfer of the shares to the individual.

     6.4 VESTING  GENERALLY.  The total number of shares of Common Stock subject
to an Option  may,  but need  not,  vest and  therefore  become  exercisable  in
periodic  installments  that may,  but need not,  be equal.  The  Option  may be
subject to such other terms and  conditions  on the time or times when it may be
exercised (which may be based on performance or other criteria) as the Board may
deem  appropriate.  The vesting  provisions of individual  Options may vary. The
provisions of this Section 6(g) are subject to any Option  provisions  governing
the  minimum  number  of shares  of  Common  Stock as to which an Option  may be
exercised.

                        7. NON-TRANSFERABILITY OF OPTIONS

     7.1  GENERAL.  No  Option  granted  under  the Plan  shall be  transferable
otherwise than by will or the laws of descent and distribution.

                          8. TERMINATION OF EMPLOYMENT

     8.1 GENERAL. If employment of the holder of an Option is terminated for any
reason, other than by death or disability,  the holder's Option may be exercised
only within three months from the date of such termination of employment, but in
no event after the Expiration Date of the Option; provided, however, that if the
holder is  dismissed  for  cause,  as to which the  Committee  shall be sole and
exclusive judge, the Option shall expire immediately.

     9.1 DEATH WHILE EMPLOYED. If the holder of an Option dies while employed by
the Company,  the Option may be exercised by the personal  representative of the
Option holder,  for a period of six (6) months from the date of death, but in no
event after the Expiration Date of the Option.

     9.2 DEATH AFTER  TERMINATION.  If the holder of an Option dies within three
months after  termination of employment  other than for cause, the Option may be
exercised by the personal  representative  of the Option  holder for a period of
six (6) months from the date the Option holder's employment was terminated,  but
in no event after the Expiration Date of the Option.

     9.3  DISABILITY.  If the holder of an Option  becomes  disabled  within the
meaning of Section  22(e)(3)  of the Code,  the Option may be  exercised  by the
Option holder within one year after his becoming disabled, but in no event after
the Expiration Date of the Option.

                          10. AMENDMENT AND TERMINATION

     10.1 TERM. Unless the Plan has been terminated as hereinafter provided, the
Plan  shall  terminate  on October  21,  2012,  and no Option  under it shall be
granted  thereafter.  The Board of Directors of the Company at any time prior to
that date may terminate the Plan.

     10.2  AMENDMENT.  The Board of Directors  may also amend the Plan by making
such changes and  additions to it as the Board shall deem  advisable;  provided,
however,  that except as provided in Section 3.2 hereof,  the Board of Directors
may not, without further  approval by the Shareholders of the Company,  increase
the maximum  number of shares as to which  Options may be granted or  exercised;
and  provided  further,  that any such  change or  addition  does not affect the
Plan's status under Section 422 of the Code. No  termination or amendment of the
Plan  may,  without  the  consent  of the  holder of an  Option  then  existing,
terminate  his Option or materially  and  adversely  affect his rights under the
Option.

                               11. EFFECTIVE DATE

     11.1 SHAREHOLDER APPROVAL. The Plan shall become effective upon adoption by
the Board of Directors of the Company, provided that it shall be approved by the
vote of the holders of a majority  of the shares of Common  Stock of the Company
outstanding and entitled to vote at a meeting of shareholders held within twelve
(12) months after the Plan is adopted by the Board of Directors.

                         12. TIME OF GRANTING OF OPTIONS

     12.1 FORMAL  GRANTING.  Nothing  contained in the Plan or in any resolution
adopted or to be adopted by the Board of  Directors or the  shareholders  of the
Company shall constitute the granting of an Option hereunder. The granting of an
Option  pursuant  to the Plan and the  acquisition  of any  rights  as an Option
holder shall take place only when the  Committee  authorizes  the issuance of an
Option,  and a formal written and executed  Option  agreement is executed by the
holder of the Option.

     12.2 TEN YEAR LIMIT.  Subject to the  provisions of Article 10, Options may
be  granted  under  the Plan  within  ten (10)  years  from the date the Plan is
adopted  by the  Board  of  Directors  of the  Company  or the  date the Plan is
approved by the Shareholders, whichever is earlier.

                          13. MISCELLANEOUS PROVISIONS

     13.1 OPTION DATE.  An Option shall have been deemed to have been granted on
the date fixed in the  resolution of the Committee  authorizing  the granting of
such Option,  provided  such date shall not be prior to the date of the adoption
of such resolution. If no date is fixed by such resolution,  the Option shall be
deemed to have been granted on the date of adoption of the resolution,  provided
that the agreement relating to the Option shall be executed and delivered within
thirty (30) days  therefrom;  otherwise  the Option shall be deemed to have been
granted on the date of delivery of such agreement to the optionee.

     13.2  INDEMNIFICATION  OF COMMITTEE.  Without  limiting any other rights of
indemnification,  the  members  of the  Committee  shall be  indemnified  by the
Company against the reasonable expenses (including  attorney's fees,  judgments,
fines,  and amounts  paid in  settlement)  actually  incurred as a result of any
action,  suit or proceeding,  or any appeal therein ("Claim"),  to which they or
any of them may be a party by reason of any action taken or failure to act under
or in  connection  with  the  Plan,  and  against  all  amounts  paid by them in
settlement  of such Claim,  to the full extent  permissible  under  Florida Law;
provided that within sixty (60) days after  institution  of any such Claim,  the
Committee member involved offers the Company in writing the opportunity,  at its
Own expense, to handle and defend the same.

     13.3  JURISDICTION AND VENUE.  This Agreement shall be governed by the laws
of the state of Florida and any litigation  with respect to this Agreement shall
be in the state or Federal courts situated in Broward County, Florida.


                                                  _______________
                                                  Peter G. Dornau

                                                  ________________
                                                  Edward Anchel

                                                  ________________
                                                  James Kolisch

                                                  _________________
                                                  Laz L. Schneider

                                                  _________________
                                                  John B. Turner

                                                  ________________
                                                  Sonia B. Beard

                                                  _________________
                                                  William W. Dudman


                                                  _________________
                                                  Jeffrey S. Barocas

                                                  ________________
                                                  Gregor M. Dornau